FDA Submission for Administering The Hatch-Waxman Amendments: Ensuring A Balance Between Innovation And Access FDA Submission for Administering The Hatch-Waxman Amendments: Ensuring A Balance Between Innovation And Access – I-MAK

FDA Submission for Administering The Hatch-Waxman Amendments: Ensuring A Balance Between Innovation And Access

17 Sep 2017
View Resource

“Administering the Hatch-Waxman Amendments: Ensuring a Balance Between Innovation and Access” was a meeting held on July 18, 2017 to provide the public an opportunity to submit comments concerning administration of the Hatch-Waxman Amendments to the Federal Food, Drug, and Cosmetic Act (FD&C Act) to help ensure the intended balance between encouraging innovation in drug development and accelerating the availability to the public of lower cost alternatives to innovator drugs is maintained. Read I-MAK’s submission.

Partner with us now to build
a more just and equitable
medicine system for all.